Ficlatuzumab
Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers. Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer.
Link from a Wikipage to another Wikipage
primaryTopic
Ficlatuzumab
Ficlatuzumab is a humanized monoclonal antibody designed for the treatment of cancers. Ficlatuzumab was developed by AVEO Pharmaceuticals. In May 2012, AVEO released results of a Phase II clinical trial comparing gefitinib alone and in combination with ficlatuzamab in treatment-naive Asian patients with non-small cell lung cancer.
has abstract
Ficlatuzumab is a humanized mo ...... th non-small cell lung cancer.
@en
Le ficlatuzumab (AV-299) est u ...... atocyte growth factor ou HGF).
@fr
فيكلاتوزوماب هو جسم مضاد وحيد ...... دامه مع فيكلاتوزوماب في علاج .
@ar
CAS number
1174900-84-5
FDA UNII code
77E89833TG
KEGG
Wikipage page ID
33,023,995
page length (characters) of wiki page
Wikipage revision ID
999,591,640
Link from a Wikipage to another Wikipage
ATC prefix
none
@en
CAS number
ChemSpiderID
none
@en
KEGG
D10123
@en
mab type
mab
@en
source
zu/o
@en
target
type
mab
@en
Verifiedfields
changed
@en
verifiedrevid
457,119,832
Watchedfields
changed
@en
wikiPageUsesTemplate
subject
hypernym
comment
Ficlatuzumab is a humanized mo ...... th non-small cell lung cancer.
@en
Le ficlatuzumab (AV-299) est u ...... atocyte growth factor ou HGF).
@fr
فيكلاتوزوماب هو جسم مضاد وحيد ...... دامه مع فيكلاتوزوماب في علاج .
@ar
label
Ficlatuzumab
@en
Ficlatuzumab
@fr
فيكلاتوزوماب
@ar